Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Assets (2016 - 2025)

Historic Return on Assets for vTv Therapeutics (VTVT) over the last 11 years, with Q3 2025 value amounting to 0.45%.

  • vTv Therapeutics' Return on Assets rose 600.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.92% for FY2024, which is 2500.0% up from last year.
  • Per vTv Therapeutics' latest filing, its Return on Assets stood at 0.45% for Q3 2025, which was up 600.0% from 0.82% recorded in Q2 2025.
  • vTv Therapeutics' 5-year Return on Assets high stood at 0.25% for Q3 2021, and its period low was 2.0% during Q4 2023.
  • Moreover, its 5-year median value for Return on Assets was 0.73% (2022), whereas its average is 0.77%.
  • As far as peak fluctuations go, vTv Therapeutics' Return on Assets skyrocketed by 23900bps in 2021, and later plummeted by -12700bps in 2023.
  • vTv Therapeutics' Return on Assets (Quarter) stood at 0.62% in 2021, then decreased by -17bps to 0.73% in 2022, then crashed by -174bps to 2.0% in 2023, then skyrocketed by 72bps to 0.56% in 2024, then grew by 19bps to 0.45% in 2025.
  • Its last three reported values are 0.45% in Q3 2025, 0.82% for Q2 2025, and 0.65% during Q1 2025.